|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 239/48 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3209647 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15787846.3 |
| Europos patento paraiškos padavimo data | 2015-10-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-06-03 |
| (46) | Apibrėžties vertimo paskelbimo data | 2020-09-25 |
| (86) | Numeris | PCT/US2015/056701 |
| Data | 2015-10-21 |
| (87) | Numeris | WO 2016/065028 |
| Data | 2016-04-28 |
| (30) | Numeris | Data | Šalis |
| 201462066849 P | 2014-10-21 | US |
| (72) |
ROZAMUS, Leonard, W., US
SHARMA, Pradeep, US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka,
JP
|
| (74) |
| (54) | Kristalinės 5-chlor-N4-[-2-(dimetilfosforil)fenil]-N2-{2-metoksi-4-[4-(4-metilpiperazin-1-il) piperidin-1-il]pirimidin-2,4-diamino formos |
| CRYSTALLINE FORMS OF 5-CHLORO-N4-[-2-(DIMETHYLPHOSPHORYL) PHENYL]-N2-{2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL) PIPERIDIN-1-YL]PYRIMIDINE-2,4-DIAMINE |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-09-23 | 11 | 289.00 EUR |
| 2026-10-21 |